Weill Cornell
New York, NY
Accepting patients
Orca-T
A Phase 2 Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- T Cell (Allogeneic)
- Allogeneic Stem Cell Transplant
- Phase 2
Accepting patients
Safety Study of Cord Blood Units
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
- Allogeneic Stem Cell Transplant
- Phase 2
Not currently accepting
Luspatercept and Lenalidomide (L2)
A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
- Immunomodulatory Drug
- Red Blood Cell Stimulant
- Erythroid Maturation Agent (EMA)
- Phase 1/2